Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Gut Decontamination Using Rifaximin in the Patients With Severe Alcoholic Hepatitis

NCT02485106 is registered in ClinicalTrials.gov with Saint Vincent's Hospital, Korea as lead sponsor.

NCT NCT02485106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02485106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Gut Decontamination Using Rifaximin in the Patients With Severe Alcoholic Hepatitis
Lead sponsor
Saint Vincent's Hospital, Korea
Phase
Phase 3
Overall status
Unknown status
Start date
July 31, 2015
Completion date
Not reported
Enrollment
170 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

severe alcoholic hepatitis